Authors:
OBOYLE KP
SENTER PD
BHARGAVA K
CHUN S
ANTHONY G
MARKOWITZ AL
WADLER S
Citation: Kp. Oboyle et al., EFFECTS OF A HYBRID RECOMBINANT HUMAN ALPHA-INTERFERON (A D) ON IN-VITRO CYTOTOXICITY AND IN-VIVO LOCALIZATION OF MONOCLONAL-ANTIBODY L6-CYTOSINE DEAMINASE CONJUGATE IN A COLON-CANCER MODEL/, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 33-42
Authors:
KERR DE
LI ZG
SIEMERS NO
SENTER PD
VRUDHULA VM
Citation: De. Kerr et al., DEVELOPMENT AND ACTIVITIES OF A NEW MELPHALAN PRODRUG DESIGNED FOR TUMOR-SELECTIVE ACTIVATION, Bioconjugate chemistry, 9(2), 1998, pp. 255-259
Citation: Hp. Svensson et al., THERAPEUTIC EFFECTS OF MONOCLONAL ANTIBODY-BETA-LACTAMASE CONJUGATES IN COMBINATION WITH A NITROGEN-MUSTARD ANTICANCER PRODRUG IN MODELS OFHUMAN RENAL-CELL CARCINOMA, Journal of medicinal chemistry, 41(9), 1998, pp. 1507-1512
Authors:
ABOAGYE EO
ARTEMOV D
SENTER PD
BHUJWALLA ZM
Citation: Eo. Aboagye et al., INTRATUMORAL CONVERSION OF 5-FLUOROCYTOSINE TO 5-FLUOROURACIL BY MONOCLONAL-ANTIBODY CYTOSINE DEAMINASE CONJUGATES - NONINVASIVE DETECTION OF PRODRUG ACTIVATION BY MAGNETIC-RESONANCE SPECTROSCOPY AND SPECTROSCOPIC IMAGING, Cancer research, 58(18), 1998, pp. 4075-4078
Authors:
SIEMERS NO
KERR DE
YARNOLD S
STEBBINS MR
VRUDHULA VM
HELLSTROM I
HELLSTROM KE
SENTER PD
Citation: No. Siemers et al., CONSTRUCTION, EXPRESSION, AND ACTIVITIES OF L49-SFV-BETA-LACTAMASE, ASINGLE-CHAIN ANTIBODY FUSION PROTEIN FOR ANTICANCER PRODRUG ACTIVATION, Bioconjugate chemistry, 8(4), 1997, pp. 510-519
Citation: M. Jung et al., BIOORGANOMETALLIC CHEMISTRY - SYNTHESIS AND ANTITUMOR-ACTIVITY OF COBALT CARBONYL-COMPLEXES, Archiv der pharmazie, 330(6), 1997, pp. 173-176
Citation: Vm. Vrudhula et al., IMMUNOLOGICALLY SPECIFIC ACTIVATION OF A CEPHALOSPORIN DERIVATIVE OF MITOMYCIN-C BY MONOCLONAL-ANTIBODY BETA-LACTAMASE CONJUGATES, Journal of medicinal chemistry, 40(17), 1997, pp. 2788-2792
Authors:
SENTER PD
MARQUARDT H
THOMAS BA
HAMMOCK BD
FRANK IS
SVENSSON HP
Citation: Pd. Senter et al., THE ROLE OF RAT SERUM CARBOXYLESTERASE IN THE ACTIVATION OF PACLITAXEL AND CAMPTOTHECIN PRODRUGS, Cancer research, 56(7), 1996, pp. 1471-1474
Authors:
SIEMERS NO
YELTON DE
BAJORATH J
SENTER PD
Citation: No. Siemers et al., MODIFYING THE SPECIFICITY AND ACTIVITY OF THE ENTEROBACTER-CLOACAE P99 BETA-LACTAMASE BY MUTAGENESIS WITHIN AN M13 PHAGE VECTOR, Biochemistry, 35(7), 1996, pp. 2104-2111
Authors:
HAYDEN MS
GROSMAIRE LS
NORRIS NA
GILLILAND LK
WINBERG G
TRITSCHLER D
TSU TT
LINSLEY PS
MITTLER RS
SENTER PD
FELL HP
LEDBETTER JA
Citation: Ms. Hayden et al., COSTIMULATION BY CD28 SFV EXPRESSED ON THE TUMOR-CELL SURFACE OR AS ASOLUBLE BISPECIFIC MOLECULE TARGETED TO THE L6 CARCINOMA ANTIGEN, Tissue antigens, 48(4-I), 1996, pp. 242-254
Citation: Vm. Vrudhula et al., CEPHALOSPORIN DERIVATIVES OF DOXORUBICIN AS PRODRUGS FOR ACTIVATION BY MONOCLONAL ANTIBODY-BETA-LACTAMASE CONJUGATES, Journal of medicinal chemistry, 38(8), 1995, pp. 1380-1385
Authors:
KERR DE
SCHREIBER GJ
VRUDHULA VM
SVENSSON HP
HELLSTROM I
HELLSTROM KE
SENTER PD
Citation: De. Kerr et al., REGRESSIONS AND CURES OF MELANOMA XENOGRAFTS FOLLOWING TREATMENT WITHMONOCLONAL-ANTIBODY BETA-LACTAMASE CONJUGATES IN COMBINATION WITH ANTICANCER PRODRUGS, Cancer research, 55(16), 1995, pp. 3558-3563
Authors:
SVENSSON HP
VRUDHULA VM
EMSWILER JE
MACMASTER JF
COSAND WL
SENTER PD
WALLACE PM
Citation: Hp. Svensson et al., IN-VITRO AND IN-VIVO ACTIVITIES OF A DOXORUBICIN PRODRUG IN COMBINATION WITH MONOCLONAL-ANTIBODY BETA-LACTAMASE CONJUGATES, Cancer research, 55(11), 1995, pp. 2357-2365
Citation: D. Hollenbaugh et al., EFFECTS OF CHEMICAL MODIFICATION ON THE BINDING ACTIVITIES OF P-SELECTIN MUTANTS, Biochemistry, 34(16), 1995, pp. 5678-5684
Citation: Hp. Svensson et al., SYNTHESIS AND CHARACTERIZATION OF MONOCLONAL ANTIBODY-BETA-LACTAMASE CONJUGATES, Bioconjugate chemistry, 5(3), 1994, pp. 262-267
Authors:
SAULNIER MG
LANGLEY DR
KADOW JF
SENTER PD
KNIPE JO
TUN MM
VYAS DM
DOYLE TW
Citation: Mg. Saulnier et al., SYNTHESIS OF ETOPOSIDE PHOSPHATE, BMY-40481 - A WATER-SOLUBLE CLINICALLY ACTIVE PRODRUG OF ETOPOSIDE, Bioorganic & medicinal chemistry letters, 4(21), 1994, pp. 2567-2572
Authors:
SVENSSON HP
SENTER PD
VRUDHULA VM
WALLACE PM
Citation: Hp. Svensson et al., IN-VITRO AND IN-VIVO ACTIVITIES OF A DOXORUBICIN PRODRUG IN COMBINATION WITH A MONOCLONAL ANTIBODY-BETA-LACTAMASE CONJUGATE, Journal of cellular biochemistry, 1994, pp. 112-112
Citation: Pm. Wallace et Pd. Senter, SELECTIVE ACTIVATION OF ANTICANCER PRODRUGS BY MONOCLONAL-ANTIBODY ENZYME CONJUGATES, Methods and findings in experimental and clinical pharmacology, 16(7), 1994, pp. 505-512
Authors:
WALLACE PM
MACMASTER JF
SMITH VF
KERR DE
SENTER PD
COSAND WL
Citation: Pm. Wallace et al., INTRATUMORAL GENERATION OF 5-FLUOROURACIL MEDIATED BY AN ANTIBODY CYTOSINE DEAMINASE CONJUGATE IN COMBINATION WITH 5-FLUOROCYTOSINE, Cancer research, 54(10), 1994, pp. 2719-2723
Authors:
VRUDHULA VM
SVENSSON HP
KENNEDY KA
SENTER PD
WALLACE PM
Citation: Vm. Vrudhula et al., ANTITUMOR ACTIVITIES OF A CEPHALOSPORIN PRODRUG IN COMBINATION WITH MONOCLONAL ANTIBODY-BETA-LACTAMASE CONJUGATES, Bioconjugate chemistry, 4(5), 1993, pp. 334-340
Authors:
KERR DE
GARRIGUES US
WALLACE PM
HELLSTROM KE
HELLSTROM I
SENTER PD
Citation: De. Kerr et al., APPLICATION OF MONOCLONAL-ANTIBODIES AGAINST CYTOSINE DEAMINASE FOR THE IN-VIVO CLEARANCE OF A CYTOSINE DEAMINASE IMMUNOCONJUGATE, Bioconjugate chemistry, 4(5), 1993, pp. 353-357
Authors:
GOSHORN SC
SVENSSON HP
KERR DE
SOMERVILLE JE
SENTER PD
FELL HP
Citation: Sc. Goshorn et al., GENETIC CONSTRUCTION, EXPRESSION, AND CHARACTERIZATION OF A SINGLE-CHAIN ANTI-CARCINOMA ANTIBODY FUSED TO BETA-LACTAMASE, Cancer research, 53(9), 1993, pp. 2123-2127